ledipasvir

Term ID

CHEBI:85089

Synonyms

GS 5885
GS-5885
GS5885
methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbama
WHO 9796

Definition

A benzimidazole derivative that is used in combination with sofosbuvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: azaspiro compound benzimidazole bridged compound carbamate ester carboxamide ... Show All 10 Terms

azaspiro compound benzimidazole bridged compound carbamate ester carboxamide fluorenes imidazoles L-valine derivative N-acylpyrrolidine organofluorine compound Show first 5 Terms
has_role: antiviral drug hepatitis C protease inhibitor

antiviral drug hepatitis C protease inhibitor Show first 5 Terms
inverse has_part: Harvoni

Harvoni Show first 5 Terms

Phenotype

Phenotype resulting from ledipasvir

Phenotype where environments contain ledipasvir

Phenotype modified by environments containing ledipasvir

Human Disease Model